Search Results - "VINOLAS, N"

Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: an exploratory longitudinal study by Viñolas, N. Nuria, Garcia-Campelo, Rosario, Majem, Margarita, Carcereny, Enric, Isla, Dolores, Gonzalez-Larriba, José Luis, Coves, Juan, De-Castro, Javier, Domine, Manuel, Lianes, Piar, Artal, Angel, Remon, Jordi, Felip, Enriqueta, Garrido, Pilar

“…Background Little is known about the impact of sex on lung cancer patients from the psychological, economic and social perspectives. This study was designed to…”
Get full text

Sleeve lobectomy after induction chemoradiotherapy by Gómez-Caro, Abel, Boada, Marc, Reguart, Noemí, Viñolas, Nuria, Casas, Frances, Molins, Laureano

“…OBJECTIVES The effect of induction chemoradiotherapy (CRT) on bronchial anastomoses remains uncertain. This prospective study aimed to assess the impact of…”
Get full text

Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types by Paré, L., Pascual, T., Seguí, E., Teixidó, C., Gonzalez-Cao, M., Galván, P., Rodríguez, A., González, B., Cuatrecasas, M., Pineda, E., Torné, A., Crespo, G., Martin-Algarra, S., Pérez-Ruiz, E., Reig, Ò, Viladot, M., Font, C., Adamo, B., Vidal, M., Gaba, L., Muñoz, M., Victoria, I., Ruiz, G., Viñolas, N., Mellado, B., Maurel, J., Garcia-Corbacho, J., Molina-Vila, M Á, Juan, M., Llovet, J.M., Reguart, N., Arance, A., Prat, A.

“…We hypothesized that the abundance of PD1 mRNA in tumor samples might explain the differences in overall response rates (ORR) observed following anti-PD1…”
Get full text

Cell-free DNA concentration and fragment size fraction correlate with FDG PET/CT-derived parameters in NSCLC patients by González de Aledo-Castillo, JM, Casanueva-Eliceiry, S., Soler-Perromat, A., Fuster, D., Pastor, V., Reguart, N., Viñolas, N., Reyes, R., Vollmer, I., Paredes, P., Puig-Butillé, JA

“…Purpose The aim of our study was to investigate the correlation between cfDNA concentration and fragment size fraction with FDG PET/CT- and CT-derived…”
Get full text

SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015 by García-Campelo, R., Bernabé, R., Cobo, M., Corral, J., Coves, J., Dómine, M., Nadal, E., Rodriguez-Abreu, D., Viñolas, N., Massuti, B.

“…Lung cancer is the most common cancer worldwide as well as the leading cause of cancer related deaths as reported by Torre et al (CA Cancer J Clin 65:87–108,…”
Get full text

Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions by Mayo-de-las-Casas, C., Jordana-Ariza, N., Garzón-Ibañez, M., Balada-Bel, A., Bertrán-Alamillo, J., Viteri-Ramírez, S., Reguart, N., Muñoz-Quintana, M.A., Lianes-Barragan, P., Camps, C., Jantús, E., Remon-Massip, J., Calabuig, S., Aguiar, D., Gil, M.L., Viñolas, N., Santos-Rodríguez, A.K., Majem, M., García-Peláez, B., Villatoro, S., Pérez-Rosado, A., Monasterio, J.C., Ovalle, E., Catalán, M.J., Campos, R., Morales-Espinosa, D., Martínez-Bueno, A., González-Cao, M., González, X., Moya-Horno, I., Sosa, A.E., Karachaliou, N., Rosell, R., Molina-Vila, M.A.

“…In a significant percentage of advanced non-small-cell lung cancer (NSCLC) patients, tumor tissue is unavailable or insufficient for genetic analyses. We…”
Get full text

Trained dogs can identify malignant solitary pulmonary nodules in exhaled gas by Guirao, A., Molins, L., Ramón, I., Sunyer, G., Viñolas, N., Marrades, R., Sánchez, D., Fibla, J.J., Boada, M., Hernández, J., Guzmán, R., Libreros, A., Gómez-Caro, A., Guerrero, C., Agustí, A.

“…[Display omitted] •Exhaled air LC detection by trained dogs has high diagnostic rate (incl. tumors <3 cm).•Canine LC detection enables research on…”
Get full text

Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial by Camps, C., Massuti, B., Jiménez, A., Maestu, I., Gómez, R. García, Isla, D., González, J. L., Almenar, D., Blasco, A., Rosell, R., Carrato, A., Viñolas, N., Batista, N., Girón, C. García, Galán, A., López, M., Blanco, R., Provencio, M., Diz, P., Felip, E.

“…Background: Docetaxel is a widely accepted second-line treatment in advanced non-small-cell lung cancer (NSCLC) with a risk of myelotoxicity. This study…”
Get full text

A consensus statement on the gender perspective in lung cancer by Isla, D., Majem, M., Viñolas, N., Artal, A., Blasco, A., Felip, E., Garrido, P., Remón, J., Baquedano, M., Borrás, J. M., Die Trill, M., García-Campelo, R., Juan, O., León, C., Lianes, P., López-Ríos, F., Molins, L., Planchuelo, M. Á., Cobo, M., Paz-Ares, L., Trigo, J. M., de Castro, J.

“…Lung cancer is the most common cancer globally and has the highest mortality. Although this disease is not associated with a particular gender, its incidence…”
Get full text

Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine by Viñolas, N, Provencio, M, Reguart, N, Cardenal, F, Alberola, V, Sánchez-Torres, J.M, Barón, F.J, Cobo, M, Maestu, I, Moreno, I, Mesía, C, Izquierdo, A, Felip, E, López-Brea, M, Márquez, A, Sánchez-Ronco, M, Tarón, M, Santarpia, M.C, Rosell, R

“…Abstract New therapeutic approaches are being developed based on the findings that several genetic abnormalities underlying NSCLC could influence…”
Get full text

Effect of central nervous system (CNS) metastases in a real-world multicenter cohort study of Spanish ALK-positive non-small cell lung cancer (NSCLC) patients (p) by Angelats, L., Garcia Campelo, M.R., Bernabe Caro, R., Arriola Aperribay, E., Calvo de Juan, V., Barba Joaquín, A., Vinolas Segarra, N., Gil Moreno, M.D.L.L., Vilà Martinez, L., Juan Vidal, O.J., Vilariño Quintela, N., Cobo, M., Sais, E., Domine Gomez, M., Fernandez Nuñez, N., Coves Sarto, J., Marse Fabregat, R., Esteve Gomez, A.M., Rodríguez-Abreu, D., Carcereny Costa, E.

Get full text

Successful Oral Desensitization in a Patient With Hypersensitivity Reaction to Crizotinib by Sánchez-López, J, Viñolas, N, Muñoz-Cano, R, Pascal, M, Reguart, N, Bartra, J, Valero, A

Get full text

LungBEAM: A prospective multicenter trial to monitor EGFR mutations using BEAMing technology in stage IV NSCLC patients by Garrido Lopez, P., Felip, E., Paz-Ares, L., Majem, M., Moran, T., Gonzalez-Larriba, J.L., Bosch Barrera, J., Trigo Perez, J.M., Garcia Campelo, M.R., Sanchez Torres, J.M., Isla, D., Vinolas Segarra, N., Camps, C., Insa Molla, A., Juan Vidal, O.J., Massutí, B., Paredes Lario, A., Artal-Cortes, A., Lopez-Brea Piqueras, M., Palacios Calvo, J.

Get full text

Final results of RENO study: Randomized phase II of oral vinorelbine or etoposide with cisplatin & chemo-radiation in stage III NSCLC - SLCG 10/02 by Provencio Pulla, M., de las Peñas, R., Martinez Banaclocha, N., MarsÉ Fabregat, R., Insa Molla, A., Moran, T., Sala Gonzalez, M.A., Massuti Sureda, B., Mut Sanchis, P., Ortega Granados, A.L., Jurado, J.M., Gomez Codina, J., Artal-Cortes, A., Vazquez, F., Gutierrez Calderon, V., Diz Tain, P., Vinolas Segarra, N., Maestu Maiques, I., Camps, C., Isla Casado, M.D.

Get full text

Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors by Molina, R, Filella, X, Augé, J M, Fuentes, R, Bover, I, Rifa, J, Moreno, V, Canals, E, Viñolas, N, Marquez, A, Barreiro, E, Borras, J, Viladiu, P

“…CEA, CA 125, SCC, CYFRA 21-1 and NSE were prospectively studied in 211 patients with non-small cell lung cancer and compared with clinical parameters (age,…”
Get more information

Lung cancer in women: an overview with special focus on Spanish women by Remon, J., Molina-Montes, E., Majem, M., Lianes, P., Isla, D., Garrido, P., Felip, E., Viñolas, N., de Castro, J., Artal, A., Sánchez, M.-J.

“…Lung cancer incidence is decreasing worldwide among men but rising among women due to recent changes in smoking patterns in both sexes. In Europe, the smoking…”
Get full text

PO-0681: Randomized phase II study of Erlotinib with radiotherapy in irresectable non small cell lung cancer by Martinez, E, Oses, M. Rico, Casas, F, Viñolas, N, Minguez, J, Paredes, A, Casas, A. Pérez, Domine, E

Get full text

Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival by Graus, F, Dalmou, J, Reñé, R, Tora, M, Malats, N, Verschuuren, J J, Cardenal, F, Viñolas, N, Garcia del Muro, J, Vadell, C, Mason, W P, Rosell, R, Posner, J B, Real, F X

“…Anti-Hu antibodies (HuAb) recognize antigens expressed by neurons and small-cell lung cancer (SCLC). High titers of HuAb were initially reported in serum from…”
Get more information

Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database by Remon, J., Isla, D., Garrido, P., de Castro, J., Majem, M., Viñolas, N., Artal, A., Carcereny, E., García-Campelo, M. R., Lianes, P., Provencio, M., Juan, O., Diz, P., Blanco, R., Lopez-Castro, R., Maestu, I., Vadell, C., Felip, E.

“…Background The WORLD07 project is a female specific database to assess the characteristics of women with lung cancer. Methods WORLD07 database sets up in 2007,…”
Get full text

Serum immunoglobulins in B-chronic lymphocytic leukemia. Natural history and prognostic significance by Rozman, C, Montserrat, E, Viñolas, N

“…To investigate the prognostic significance of gammaglobulin and immunoglobulin levels in chronic lymphocytic leukemia (CLL), survival studies were performed in…”
Get more information